Table of Contents

2019-2024 Global Cell Transplant Market Report (Status and Outlook)

1 Scope of the Report

• 1.1 Market Introduction
• 1.2 Research Objectives
• 1.3 Years Considered
• 1.4 Market Research Methodology
• 1.5 Economic Indicators
• 1.6 Currency Considered

2 Executive Summary

• 2.1 World Market Overview
  • 2.1.1 Global Cell Transplant Market Size 2014-2024
  • 2.1.2 Cell Transplant Market Size CAGR by Region
• 2.2 Cell Transplant Segment by Type
  • 2.2.1 Peripheral Blood Stem Cells Transplant (PBSCT)
  • 2.2.2 Bone Marrow Transplant (BMT)
  • 2.2.3 Cord Blood Transplant (CBT)
• 2.3 Cell Transplant Market Size by Type
  • 2.3.1 Global Cell Transplant Market Size Market Share by Type (2014-2019)
  • 2.3.2 Global Cell Transplant Market Size Growth Rate by Type (2014-2019)
• 2.4 Cell Transplant Segment by Application
  • 2.4.1 Hospitals
  • 2.4.2 Clinics
  • 2.4.3 Others
• 2.5 Cell Transplant Market Size by Application
  • 2.5.1 Global Cell Transplant Market Size Market Share by Application (2014-2019)
  • 2.5.2 Global Cell Transplant Market Size Growth Rate by Application (2014-2019)

3 Global Cell Transplant by Players

• 3.1 Global Cell Transplant Market Size Market Share by Players
  • 3.1.1 Global Cell Transplant Market Size by Players (2017-2019)
  • 3.1.2 Global Cell Transplant Market Size Market Share by Players (2017-2019)
• 3.2 Global Cell Transplant Key Players Head office and Products Offered
• 3.3 Market Concentration Rate Analysis
  • 3.3.1 Competition Landscape Analysis
  • 3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
• 3.4 New Products and Potential Entrants
• 3.5 Mergers & Acquisitions, Expansion

4 Cell Transplant by Regions

• 4.1 Cell Transplant Market Size by Regions
• 4.2 Americas Cell Transplant Market Size Growth
• 4.3 APAC Cell Transplant Market Size Growth
• 4.4 Europe Cell Transplant Market Size Growth
• 4.5 Middle East & Africa Cell Transplant Market Size Growth

5 Americas

• 5.1 Americas Cell Transplant Market Size by Countries
• 5.2 Americas Cell Transplant Market Size by Type
• 5.3 Americas Cell Transplant Market Size by Application
• 5.4 United States
• 5.5 Canada
• 5.6 Mexico
• 5.7 Key Economic Indicators of Few Americas Countries

6 APAC

• 6.1 APAC Cell Transplant Market Size by Countries
• 6.2 APAC Cell Transplant Market Size by Type
• 6.3 APAC Cell Transplant Market Size by Application
• 6.4 China
• 6.5 Japan
• 6.6 Korea
• 6.7 Southeast Asia
• 6.8 India
• 6.9 Australia
• 6.10 Key Economic Indicators of Few APAC Countries

7 Europe

• 7.1 Europe Cell Transplant by Countries
• 7.2 Europe Cell Transplant Market Size by Type
• 7.3 Europe Cell Transplant Market Size by Application
• 7.4 Germany
• 7.5 France
• 7.6 UK
• 7.7 Italy
• 7.8 Russia
• 7.9 Spain
• 7.10 Key Economic Indicators of Few Europe Countries

8 Middle East & Africa

• 8.1 Middle East & Africa Cell Transplant by Countries
• 8.2 Middle East & Africa Cell Transplant Market Size by Type
• 8.3 Middle East & Africa Cell Transplant Market Size by Application
• 8.4 Egypt
• 8.5 South Africa
• 8.6 Israel
• 8.7 Turkey
• 8.8 GCC Countries

9 Market Drivers, Challenges and Trends

• 9.1 Market Drivers and Impact
  • 9.1.1 Growing Demand from Key Regions
  • 9.1.2 Growing Demand from Key Applications and Potential Industries
• 9.2 Market Challenges and Impact
• 9.3 Market Trends

10 Global Cell Transplant Market Forecast

• 10.1 Global Cell Transplant Market Size Forecast (2019-2024)
• 10.2 Global Cell Transplant Forecast by Regions
  • 10.2.1 Global Cell Transplant Forecast by Regions (2019-2024)
  • 10.2.2 Americas Market Forecast
  • 10.2.3 APAC Market Forecast
  • 10.2.4 Europe Market Forecast
  • 10.2.5 Middle East & Africa Market Forecast
• 10.3 Americas Forecast by Countries
  • 10.3.1 United States Market Forecast
  • 10.3.2 Canada Market Forecast
  • 10.3.3 Mexico Market Forecast
  • 10.3.4 Brazil Market Forecast
• 10.4 APAC Forecast by Countries
  • 10.4.1 China Market Forecast
  • 10.4.2 Japan Market Forecast
  • 10.4.3 Korea Market Forecast
  • 10.4.4 Southeast Asia Market Forecast
  • 10.4.5 India Market Forecast
  • 10.4.6 Australia Market Forecast
• 10.5 Europe Forecast by Countries
  • 10.5.1 Germany Market Forecast
  • 10.5.2 France Market Forecast
  • 10.5.3 UK Market Forecast
  • 10.5.4 Italy Market Forecast
  • 10.5.5 Russia Market Forecast
  • 10.5.6 Spain Market Forecast
• 10.6 Middle East & Africa Forecast by Countries
  • 10.6.1 Egypt Market Forecast
  • 10.6.2 South Africa Market Forecast
  • 10.6.3 Israel Market Forecast
  • 10.6.4 Turkey Market Forecast
  • 10.6.5 GCC Countries Market Forecast
• 10.7 Global Cell Transplant Forecast by Type
• 10.8 Global Cell Transplant Forecast by Application

11 Key Players Analysis

• 11.1 Regen Biopharma
  • 11.1.1 Company Details
  • 11.1.2 Cell Transplant Product Offered
  • 11.1.3 Regen Biopharma Cell Transplant Revenue, Gross Margin and Market Share (2017-2019)
  • 11.1.4 Main Business Overview
  • 11.1.5 Regen Biopharma News
• 11.2 Global Cord Blood Corporation
  • 11.2.1 Company Details
  • 11.2.2 Cell Transplant Product Offered
  • 11.2.3 Global Cord Blood Corporation Cell Transplant Revenue, Gross Margin and Market Share (2017-2019)
  • 11.2.4 Main Business Overview
  • 11.2.5 Global Cord Blood Corporation News
• 11.3 CBR Systems
  • 11.3.1 Company Details
  • 11.3.2 Cell Transplant Product Offered
  • 11.3.3 CBR Systems Cell Transplant Revenue, Gross Margin and Market Share (2017-2019)
  • 11.3.4 Main Business Overview
  • 11.3.5 CBR Systems News
• 11.4 Escape Therapeutics
  • 11.4.1 Company Details
  • 11.4.2 Cell Transplant Product Offered
  • 11.4.3 Escape Therapeutics Cell Transplant Revenue, Gross Margin and Market Share (2017-2019)
  • 11.4.4 Main Business Overview
  • 11.4.5 Escape Therapeutics News
• 11.5 Cryo-Save
  • 11.5.1 Company Details
  • 11.5.2 Cell Transplant Product Offered
  • 11.5.3 Cryo-Save Cell Transplant Revenue, Gross Margin and Market Share (2017-2019)
  • 11.5.4 Main Business Overview
  • 11.5.5 Cryo-Save News
• 11.6 Lonza Group
  • 11.6.1 Company Details
  • 11.6.2 Cell Transplant Product Offered
  • 11.6.3 Lonza Group Cell Transplant Revenue, Gross Margin and Market Share (2017-2019)
  • 11.6.4 Main Business Overview
  • 11.6.5 Lonza Group News
• 11.7 Pluristem Therapeutics
  • 11.7.1 Company Details
  • 11.7.2 Cell Transplant Product Offered
  • 11.7.3 Pluristem Therapeutics Cell Transplant Revenue, Gross Margin and Market Share (2017-2019)
  • 11.7.4 Main Business Overview
  • 11.7.5 Pluristem Therapeutics News
• 11.8 Stemedica Cell Technology
  • 11.8.1 Company Details
  • 11.8.2 Cell Transplant Product Offered
  • 11.8.3 Stemedica Cell Technology Cell Transplant Revenue, Gross Margin and Market Share (2017-2019)
  • 11.8.4 Main Business Overview
  • 11.8.5 Stemedica Cell Technology News

12 Research Findings and Conclusion

Cell Transplant is a procedure in which cells, often stem cells or cells that can be induced to become pluripotent stem cells, are transferred to a site where the tissue is damaged or diseased. The transfer can occur within an individual (autologous transplantation), between individuals, or between species.

According to this study, over the next five years the Cell Transplant market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2024, from US$ xx million in 2019. In particular, this report presents the global revenue market share of key companies in Cell Transplant business, shared in Chapter 3.

This report presents a comprehensive overview, market shares and growth opportunities of Cell Transplant market by product type, application, key companies and key regions.

This study considers the Cell Transplant value generated from the sales of the following segments:

Segmentation by product type: breakdown data from 2014 to 2019 in Section 2.3; and forecast to 2024 in section 10.7.
Peripheral Blood Stem Cells Transplant (PBSCT)
Bone Marrow Transplant (BMT)
Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 10.8.
Hospitals
Clinics
Others

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Regen Biopharma
Global Cord Blood Corporation
CBR Systems
Escape Therapeutics
Cryo-Save
Lonza Group
Pluristem Therapeutics
Stemedica Cell Technology

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key players and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives
To study and analyze the global Cell Transplant market size by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
To understand the structure of Cell Transplant market by identifying its various subsegments.
Focuses on the key global Cell Transplant players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Cell Transplant with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the size of Cell Transplant submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.